发明名称 Antibody constructs for influenza M2 and CD3
摘要 The present invention relates to an antibody construct comprising a first human binding domain specific for the extracellular part of the influenza envelope protein M2 (M2e) and a second domain specific for CD3. Moreover, the invention provides a nucleic acid molecule encoding the antibody construct, a vector comprising said nucleic acid molecule and a host cell transformed or transfected with said nucleic acid molecule or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a pharmaceutical composition comprising said antibody construct, a medical use/method of treatment relating to said antibody construct, and a kit comprising said antibody construct.
申请公布号 US9505849(B2) 申请公布日期 2016.11.29
申请号 US201414774293 申请日期 2014.03.17
申请人 AMGEN RESEARCH (MUNICH) GMBH;VIB VZW;Universiteit Gent 发明人 Kufer Peter;Raum Tobias;Muenz Markus;Pendzialek Jochen;Fiers Walter;Saelens Xavier;Roose Kenny
分类号 A61K39/42;A61K45/06;C07K16/46;C07K16/10;C07K16/28;A61K39/00 主分类号 A61K39/42
代理机构 Marshall, Gerstein & Borun LLP 代理人 Marshall, Gerstein & Borun LLP
主权项 1. An antibody construct comprising: (a) a first human binding domain comprising a CDR-H1 comprising the amino acid sequence of SEQ ID NO: 1, a CDR-H2 as comprising the amino acid sequence of SEQ ID NO: 2, a CDR-H3 as comprising the amino acid sequence of SEQ ID NO: 3, a CDR-L1 as comprising the amino acid sequence of SEQ ID NO: 4, a CDR-L2 as comprising the amino acid sequence of SEQ ID NO: 5, and a CDR-L3 as comprising the amino acid sequence of SEQ ID NO: 6; and (b) a second binding domain specific for CD3.
地址 Munich DE